healthcare test News
-
New pharmacy shop available!
Our pharmaceutical wholesale Fresco Farma has launched a new online shop for pharmacists. Every independent pharmacist can now easily purchase all of Fresco Farma's products, at a great price point. These products include: Medicines OTC-items Healthcare tests You will be asked to create an account during your first visit. After a quick verification, you can start placing ...
-
BSI extends healthcare rReach with Eurocat acquisition
BSI, the global standards and assessment body, has acquired German healthcare certification and testing business, EUROCAT. This development significantly enhances BSI’s ability to service the medical device market globally.EUROCAT is an established Notified Body offering healthcare systems and product certification. The company has a significant presence in Germany - the third largest medical ...
-
Visby Medical Executes Contract Option with BARDA for $25.5M to Develop Rapid Flu-COVID PCR Test Designed for At-Home Use
Visby Medical™, a leading medical diagnostic company, today announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority (BARDA).The developmental-stage Flu-COVID PCR Test is a single-use, handheld, all-in-one PCR device that detects and distinguishes ...
-
Abbott joins clinton health access initiative in effort to improve infant testing for HIV in Africa
Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI. A key focus of this cooperation will be sub-Saharan Africa, which the World Health Organization estimates to account for 90 percent of global HIV infections in children. Under terms of the agreement, Abbott will supply its RealTime ...
-
Why we Started (TBT): HIV Testing
Why HIV Testing is Important HIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once, and individuals deemed high risk should be tested more frequently. A positive test allows individuals to then seek treatment (there are several forms of effective treatment currently available) and prevent transmission to others. How HIV Testing ...
By Fluxergy
-
Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit. Chiricahua Community Health Centers, Inc. (CCHCI) today announced a collaboration ...
-
Ohio Launches COVID-19 Screening Program for K-12 Students and Staff
A new K-12 screening pilot, initiated by Ohio Governor Mike DeWine and administered by Thermo Fisher Scientific and Color Health, will provide testing to students, teachers and staff for COVID-19 on a weekly basis to help ensure safer in-person learning. The ReadyCheckGo testing program is now underway at the LEAP Academy in Cincinnati and the Ohio School for the Deaf and Ohio School for the ...
-
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test
Mammoth Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its DETECTR BOOST® SARS-CoV-2 Reagent Kit, a first of its kind high-throughput solution that combines the power of CRISPR with laboratory automation for SARS-CoV-2 testing. The DETECTR BOOST platform is a turnkey, CRISPR-based molecular diagnostic ...
-
Healthcare Associated Infection Exposed in New Public Outreach Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. The online video, Acinetobacter, was developed to educate the general public and healthcare providers about this potentially deadly bacterial pathogen often linked with healthcare associated infection (HAIs). Acinetobacter is a group of bacteria commonly found in soil and ...
-
CD Formulation Commences Offering of Integrated Development Services for Health Care Products
As an expert in fields like drug formulation and pharmaceutical analysis, CD Formulation has made commendable achievements. More recently, it announced to commencement of offering one-stop solutions for developing healthcare formulations. Healthcare products are increasingly prevalent among the public as they can regulate the body's functions and are suitable for specific groups of people. ...
-
Rapid COVID-19 Genome Sequencing Aids Outbreak Investigations
As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only need to know who is infected, they also need to rapidly identify which strain of the virus is spreading. To expedite such analysis, Thermo Fisher Scientific has now optimized its Ion ...
-
Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions
Beckman Coulter, a global clinical diagnostics leader, announces it will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for 69 million people with serious mental conditions worldwide. In a new agreement with Saladax Biomedical, Inc., Beckman Coulter will distribute the tests designed to measure blood levels of antipsychotic drugs ...
-
C2N Diagnostics Statement on FDA Accelerated Approval of Aducanumab forAlzheimer’s Treatment
C2N Diagnostics says the U.S. Food and Drug Administration’s (FDA) decision granting accelerated approval to aducanumab (Aduhelm) on the basis of amyloid plaque reduction for Alzheimer’s treatment represents a significant change in the ongoing fight against the horrible disease. Dr. Joel Braunstein, C2N’s CEO, said, “The accelerated approval of aducanumab will offer a ...
-
Hospitals Battle Healthcare Acquired Infections (HAIs)
An article in the August issue of Infection Control and Hospital Epidemiology discusses how researchers identified contaminated nasal spray as the cause of an outbreak of Burkholderia cepacia in patients at a Denver children’s hospital. A recent news story from WLWT last week reported on the source of a Legionnaires’ disease outbreak at an Ohio hospital in 2010. WHEC in New York ...
-
FDA Approves Breath Test To Aid In Diagnosis Of Delayed Gastric Emptying
The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis. Current tests used to diagnose gastroparesis typically involve the use of a small amount of radioactive material or imaging equipment, so testing must be conducted in specialized outpatient centers. ...
-
Alzheimer’s Breakthrough: C2N First to Offer a Widely Accessible Blood Test
Who Want Earlier Answers Patients, advocates, and physicians who have long awaited an easy to administer blood test that can help them better understand Alzheimer’s disease now have a health care innovation which they can rely upon. A breakthrough in Alzheimer’s disease has arrived with the introduction of C2N Diagnostics’ PrecivityAD™ blood test into the clinic. ...
-
AMETEK MOCON Supports Sterilization and Medical Gas Industry During COVID-19 Pandemic
AMETEK MOCON's Baseline product group, a leading provider of industrial gas chromatographs and gas sensors, is prioritizing support for specific industries to ensure healthcare supplies continue to be delivered during the COVID-19 pandemic. The company will focus on medical personal protective equipment (PPE) suppliers and sterilizers as well as impurity detection in specialty and medical gas ...
By AMETEK MOCON
-
HiberGene Diagnostics introduces brand new UK division at NEQAS event
HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...
-
New Blood Tests Help Assess Asthma Risk and Decide Pet Selection
AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity to specific proteins found in the skin, fur and saliva of these animals. ImmunoCAP Allergen Components test for Furry Animal have been cleared by the U.S. Food & Drug ...
-
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™ SARS-CoV-2 Rapid Antigen Test. The CoviDx test gives qualified healthcare providers qualitative, easy-to-interpret results within 15-20 minutes in cases of suspected COVID-19 and when performing serial ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you